University of Chicago and IDefine launch research program to develop Kleefstra syndrome treatment

---

The University of Chicago and IDefine are launching a six-month project led by Bryan Dickinson to explore a potential Kleefstra syndrome therapy. The team will develop molecular tools to boost EHMT1 protein levels, addressing the root haploinsufficiency. This early work could support future testing in patient-derived neurons and clinical delivery methods.

Čitaj dalje open_in_new